​What kinds of symptoms do patients experience before receiving treatment?

Warning symptoms include localized abdominal or pelvic pain, which may be acute or cramp-like, abnormal vaginal bleeding (often darker or brownish), general malaise, dizziness, fever, and shoulder pain (a sign of internal hemorrhage). Transvaginal abdominopelvic ultrasound shows an empty uterine cavity (no gestational sac inside). It reveals a mass or gestational sac outside the uterus, most often in a fallopian tube. On gynecological examination, the uterus appears larger than expected for the gestational age, with pain on palpation on the affected side.

​What is the impact on patients’ lives of living with these conditions?

The impact of ectopic pregnancy is severe: it is a life-threatening emergency because it can endanger the woman’s life through potential rupture of the affected organ (most often the fallopian tube) and massive internal hemorrhage, which may lead to infertility or death. Immediate physical impacts include internal bleeding (hemoperitoneum) and intense pain. This is a true vital emergency that can cause hemorrhagic shock and threaten the woman’s life. Long-term physical impacts include risk of infertility and risk of recurrence. Psychological impacts include feelings of loss, sadness, anxiety, depression, emotional distress, and sometimes post-traumatic stress.

What cultural or regional factors affect the treatment of these conditions?

Cultural factors influencing delayed care: Delayed consultation due to early pregnancy often not being declared, pelvic pain and light bleeding being trivialized, and initial use of self-medication or traditional medicine, leading to late diagnosis with frequent tubal rupture. Beliefs and perceptions about pregnancy, such as bleeding considered “normal” in early pregnancy, pain attributed to mystical or dietary causes, and fear of hospitals or surgery. Family decision-making, with the need for approval from the partner or family, delays related to family discussions, and financial dependence of women. Regional and health system factors: Limited access to healthcare due to distance from health facilities, transportation difficulties (especially during the rainy season), and delays in medical evacuation. Insufficient technical resources, including limited access to early ultrasound, beta-hCG testing, and medical treatment with methotrexate, making surgery often the only option. Shortage of qualified personnel, including gynecologists and sonographers, leading to delayed diagnosis at the primary care level. Infectious, gynecological, and epidemiological factors: High prevalence of genital infections and sexually transmitted infections that are poorly treated or untreated, resulting in tubal damage. Unsafe abortions and non-medicalized deliveries. These factors increase the incidence of ectopic pregnancy. Socio-economic factors: Low purchasing power, direct payment for healthcare, delayed consultation due to lack of financial resources, and difficulty accessing contraception.

What does the treatment process look like?

Treatment of ectopic pregnancy is mainly based on two approaches: medical treatment (methotrexate, to stop trophoblastic development) and surgical treatment (laparoscopy to remove the pregnancy, often using a conservative approach to preserve the fallopian tube).

What is the impact of this treatment on the patient’s life?

Treatment can save the life of the patient. However, there are other impacts of undergoing the experience that should be considered: Physical impact: After medical treatment with methotrexate: rapid recovery with few physical sequelae. After surgical treatment: postoperative pain, abdominal scar, longer hospitalization, and prolonged fatigue. In cases of fallopian tube removal (salpingectomy), fertility may be reduced. Psychological impact: Emotional shock related to pregnancy loss, sadness, feelings of emptiness, anxiety or guilt, fear of recurrent ectopic pregnancy, and stress related to future fertility. This psychological impact is often greater than the physical impact. Impact on fertility and reproductive life: Future pregnancies are possible in most cases. Risk of recurrence of ectopic pregnancy (approximately 10%). Anxiety during subsequent pregnancies and need for early monitoring with each new pregnancy. Impact on daily life: Temporary interruption of professional activities, fatigue limiting daily tasks, need for rest and temporary sexual abstinence, and regular medical follow-up (consultations and blood tests). Marital and social impact: Couple tensions, family pressure related to the desire for children, and feelings of stigmatization in certain communities.

What potential side effects or risks come with this treatment?

Medical treatment (methotrexate): Common and usually temporary effects include fatigue, mild to moderate pelvic pain, vaginal bleeding, nausea, vomiting, headache, and general malaise. Less frequent but possible effects include mouth irritation (aphthous ulcers), digestive disturbances, and transient elevation of liver enzymes. Potential risks include treatment failure requiring surgery, tubal rupture if the ectopic pregnancy progresses despite treatment, and teratogenic risk—pregnancy is contraindicated for at least three months after treatment. Surgical treatment: Common effects include postoperative pain, significant fatigue, abdominal scar, bloating, and constipation. Surgical risks include bleeding, infection, anesthesia-related complications, and rare injury to adjacent organs. Medium- and long-term risks include reduced fertility (especially after salpingectomy), recurrence of ectopic pregnancy, pelvic adhesions, and rarely chronic pelvic pain. Risks related to delayed treatment are often more serious than the risks of treatment itself and include tubal rupture, internal hemorrhage, hemorrhagic shock, and maternal death. Warning signs after treatment (for which care should be sought urgently) include: severe or sudden abdominal pain; dizziness, malaise, or loss of consciousness; heavy vaginal bleeding; persistent fever.

How accessible is treatment in the area? What is the typical journey like for a patient to receive care?

Access to care is often difficult due to limited capacity in healthcare facilities, lack of on-site specialists, and distance between home and healthcare centers, often 5 km, 10 km, or 15 km. Patients arrive at facilities very fatigued and often with poor general condition.

What are the alternatives to this treatment?

Treatment alternatives include medical management with methotrexate to stop growth and surgical options such as salpingotomy or salpingectomy. Patients generally prefer non-surgical methods due to fear of surgery, unless surgery becomes unavoidable.